These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8718940)

  • 1. 5-FU loaded pHEMA drainage implants for glaucoma-filtering surgery: device design and in vitro release kinetics.
    Gökce M; Akata RF; Kiremitçi-Gümüşderelioğlu M
    Biomaterials; 1996 May; 17(9):941-9. PubMed ID: 8718940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel MMC-loaded pHEMA drainage device for the treatment of glaucoma: in vitro and in vivo studies.
    Kiremitçi-Gümüşderelioglu M; Gökçe M; Akata RF
    J Biomater Sci Polym Ed; 1996; 7(10):857-69. PubMed ID: 8836832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D,L-lactide-co-glycolide).
    Wang G; Tucker IG; Roberts MS; Hirst LW
    Pharm Res; 1996 Jul; 13(7):1059-64. PubMed ID: 8842045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow release of the antimetabolite 5-fluorouracil (5-FU) from modified Baerveldt glaucoma drains to prolong drain function.
    Jacob JT; Lacour OJ; Burgoyne CF
    Biomaterials; 2001 Dec; 22(24):3329-35. PubMed ID: 11700805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles.
    Yeh MK; Tung SM; Lu DW; Chen JL; Chiang CH
    J Microencapsul; 2001; 18(4):507-19. PubMed ID: 11428679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles.
    Chouhan R; Bajpai AK
    J Mater Sci Mater Med; 2009 May; 20(5):1103-14. PubMed ID: 19132508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biodegradable controlled-release 5-FU implant in the surgery for glaucoma. Experimental study].
    Hostyn P; Villain F; Malek-Chehire N; Kühne F; Takesue Y; Parrish RK II; Parel JM
    J Fr Ophtalmol; 1996; 19(2):133-9. PubMed ID: 8731782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo drug delivery of 5-fluorouracil using poly(2-hydroxyethyl methacrylate-co-acrylamide) hydrogels.
    Blanco MD; Garcia O; Gomez C; Sastre RL; Teijon JM
    J Pharm Pharmacol; 2000 Nov; 52(11):1319-25. PubMed ID: 11186239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of degree of crosslinking on 5-fluorouracil release from poly(2-hydroxyethyl methacrylate) hydrogels.
    García O; Trigo RM; Blanco MD; Teijón JM
    Biomaterials; 1994 Jul; 15(9):689-94. PubMed ID: 7948591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(2-hydroxyethyl methacrylate) wound dressing containing ciprofloxacin and its drug release studies.
    Tsou TL; Tang ST; Huang YC; Wu JR; Young JJ; Wang HJ
    J Mater Sci Mater Med; 2005 Feb; 16(2):95-100. PubMed ID: 15744596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug loading optimization and extended drug delivery of corticoids from pHEMA based soft contact lenses hydrogels via chemical and microstructural modifications.
    García-Millán E; Koprivnik S; Otero-Espinar FJ
    Int J Pharm; 2015 Jun; 487(1-2):260-9. PubMed ID: 25891253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable controlled delivery systems for proteins based on collagen--pHEMA hydrogels.
    Rao JK; Ramesh DV; Rao KP
    Biomaterials; 1994 Apr; 15(5):383-9. PubMed ID: 8061130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the length of crosslink chain on poly(2-hydroxyethyl methacrylate) (pHEMA) swelling and biomechanical properties.
    Mabilleau G; Stancu IC; Honoré T; Legeay G; Cincu C; Baslé MF; Chappard D
    J Biomed Mater Res A; 2006 Apr; 77(1):35-42. PubMed ID: 16345096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel antiproliferative drug coating for glaucoma drainage devices.
    Ponnusamy T; Yu H; John VT; Ayyala RS; Blake DA
    J Glaucoma; 2014; 23(8):526-34. PubMed ID: 23632409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot drug delivery system for 5-fluorouracil after filtration surgery in the rabbit.
    Trope GE; Cheng YL; Sheardown H; Liu GS; Menon IA; Heathcote JG; Rootman DS; Chiu WJ; Gould L
    Can J Ophthalmol; 1994 Dec; 29(6):263-7. PubMed ID: 7834564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjunctival sustained release 5-fluorouracil for glaucoma filtration surgery.
    Cui LJ; Sun NX; Li XH; Huang J; Yang JG
    Acta Pharmacol Sin; 2008 Sep; 29(9):1021-8. PubMed ID: 18718170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation of a drug-coated glaucoma drainage device using polymer technology: in vitro and in vivo studies.
    Sahiner N; Kravitz DJ; Qadir R; Blake DA; Haque S; John VT; Margo CE; Ayyala RS
    Arch Ophthalmol; 2009 Apr; 127(4):448-53. PubMed ID: 19365022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of porous networks of poly(2-hydroxyethyl methacrylate) as interfacial drug delivery devices.
    Dziubla TD; Torjman MC; Joseph JI; Murphy-Tatum M; Lowman AM
    Biomaterials; 2001 Nov; 22(21):2893-9. PubMed ID: 11561895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer drug, ara-C, release from pHEMA hydrogels.
    Trigo RM; Blanco MD; Teijón JM; Sastre R
    Biomaterials; 1994 Nov; 15(14):1181-6. PubMed ID: 7893922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous polymeric matrix system p(HEMA-BGA) for controlled release of an anticancer drug (5-fluorouracil). II: Release kinetics.
    Denizli A; Kiremitçi M; Pişkin E
    Biomaterials; 1988 Jul; 9(4):363-6. PubMed ID: 3214661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.